Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome

Trial Profile

Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome

Recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2015

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Cardiovascular disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Nov 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
    • 07 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top